Clinical trial
Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With…
NCT00061893 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00061893 |
|---|---|
| Title | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors |
| Official title | A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination With Standard Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | celecoxib, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, vinblastine sulfate, vincristine sulfate, conventional surgery, radiation therapy, MESNA and 1 more |
| Enrollment | 38 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2013 |
| First posted | Jun 6, 2003 |
| Last update posted | Feb 15, 2019 |
| Countries | Australia, Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: